About us
CSPC Holdings Group Co., Ltd. is a national innovative enterprise integrating R&D, production and sales of innovative drugs. The group has total assets of 64 billion yuan and 28,000 employees. The company listed in Hong Kong (01093.HK) ranks among the 100 billion market value club and is a constituent stock of the Hang Seng Index. In 2019, the subsidiary company Xin Nuowei (300765.SZ) was successfully listed on the GEM, and CSPC realized a new era of "red chip + A" financing structure.
At present, there are more than 10 pharmaceutical production bases in Hebei, Shanxi, Shandong, Jiangsu, Jiangxi, Tianjin and other provinces and cities. The products are sold in more than 100 countries and regions around the world, and 36 varieties have sales of more than 100 million yuan.
CSPC has already completed a complete transformation from raw materials to preparations, from generic drugs to innovative drugs. At present, the sales revenue of innovative drugs has accounted for more than half of the group, becoming the mainstay of the group.